Vertex Pharmaceuticals (VRTX) FCF Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly FCF Margin of 43.35% for Q1 2026, up 1525.0% year-over-year from 2.67% in Q1 2025, and up 296.65% quarter-over-quarter from 10.93% in Q4 2025.
Vertex Pharmaceuticals (VRTX) FCF Margin (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' FCF Margin history runs 18 years deep, the most recent figure standing at 43.35% for Q1 2026.
- In Q1 2026, FCF Margin rose 1525.0% year-over-year to 43.35%; the TTM figure through Mar 2026 stood at 30.37% (up 4163.0% YoY), while the FY2025 annual figure was 26.61%, up 3378.0% from the prior year.
- FCF Margin for Q1 2026 stood at 43.35%, up from 10.93% in the prior quarter.
- The five-year high for FCF Margin was 49.47% in Q2 2022, with the low at 144.49% in Q2 2024.
- The 5-year median for FCF Margin is 38.61% (2022), against an average of 25.16%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin plunged 18760 bps in 2024, then jumped 17577 bps in 2025.
- Vertex Pharmaceuticals' FCF Margin stood at 45.37% in 2022, then plunged by 85 bps to 7.01% in 2023, then soared by 141 bps to 16.9% in 2024, then tumbled by 35 bps to 10.93% in 2025, then jumped by 297 bps to 43.35% in 2026.
- Business Quant data shows VRTX's FCF Margin at 43.35% in Q1 2026, 10.93% in Q4 2025, and 37.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -18,629.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.39% |
| Mar 31, 2026 | 43.35% |
| Dec 31, 2025 | 10.93% |
| Sep 30, 2025 | 37.04% |
| Jun 30, 2025 | 31.28% |
| Mar 31, 2025 | 28.09% |
| Dec 31, 2024 | 16.90% |
| Sep 30, 2024 | 46.97% |
| Jun 30, 2024 | -144.49% |
| Mar 31, 2024 | 46.02% |
| Dec 31, 2023 | 7.01% |
| Sep 30, 2023 | 49.44% |
| Jun 30, 2023 | 43.11% |
| Mar 31, 2023 | 36.12% |
| Dec 31, 2022 | 45.37% |
| Sep 30, 2022 | 38.61% |
| Jun 30, 2022 | 49.47% |
| Mar 31, 2022 | 42.56% |
| Dec 31, 2021 | 45.03% |
| Sep 30, 2021 | 44.09% |